Qualigen Therapeutics Inc (QLGN NASDAQ) stock market data APIs
$3.6595
0.09(2.5%)
as of October 17, 2025
Try our APIs with
free plan!
Qualigen Therapeutics Inc Financial Data Overview
Price chart is built with
Anychart
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was founded in 1996 and is based in Carlsbad, California.
Prev. Close
3.6595
Open
3.7467
High
3.7467
Low
3.5686
52 wk Range
1.61-10.45
Market Cap
7 583 K
P/E Ratio
0.5759
Shares Outstanding
2 033 K
Revenue
4 984 K
EPS
-1.0019
Beta
0.325
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Qualigen Therapeutics Inc data using free add-ons & libraries
Get Qualigen Therapeutics Inc Fundamental Data
Qualigen Therapeutics Inc Fundamental data includes:
- Net Revenue: 4 984 K
- EBITDA: -6 886 340
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-18
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Qualigen Therapeutics Inc News
New
Qualigen Therapeutics Announces the Official Launch of C10 Cryptocurrency Asset Treasury (DAT) Purchases: Why Is This Pullback the Golden Moment CXC10 Has Been Waiting For?
Carlsbad, CA, Oct. 12, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced the official launch of C10 Cryptocurrency Asset Treasury (DAT) purchase...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Recent Developments Include FX Signing a Deposit Agreement for 1,000 FX Super One MPV’s with ZEVO, a Pioneer of Peer-to-Peer EV Sharing Platform in the U.S.
ZEVO deposit agreement represents another innovative breakthrough in the Company’s B2B2C sales model, following the car rental, FX Par, real estate brokerage, and MCN agencies. FF Announced Pinnacle...
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
Carlsbad, CA, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced a series of key leadership and governance changes aimed at strengthenin...
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FX Finalizes U.S. Production Assembly Plan
FF has finalized the U.S. production assembly plan for FX Super One. The Company’s bridge partners and supply chain collaborators will now commence component supply for the production assembly phase...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
